Supplementary Data S6 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors

Supplementary Data S6 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors

<p>Supplementary Data 6 describes the patients included in the RNA sequencing analysis as well as AR and NEPC scores.</p>

Bewaard in:

Bibliografische gegevens
Hoofdauteur:	Naoual Menssouri (16617248) (author)
Andere auteurs:	Loïc Poiraudeau (16617251) (author), Carole Helissey (15122919) (author), Ludovic Bigot (16617254) (author), Jonathan Sabio (16617257) (author), Tony Ibrahim (16617260) (author), Cédric Pobel (16617263) (author), Claudio Nicotra (16617266) (author), Maud Ngo-Camus (16617269) (author), Ludovic Lacroix (15030059) (author), Etienne Rouleau (15009254) (author), Lambros Tselikas (15019536) (author), Anne Chauchereau (15022332) (author), Félix Blanc-Durand (15049400) (author), Alice Bernard-Tessier (16617272) (author), Anna Patrikidou (16617275) (author), Natacha Naoun (16617278) (author), Ronan Flippot (16426556) (author), Emeline Colomba (16617281) (author), Alina Fuerea (16617284) (author), Laurence Albiges (15047814) (author), Pernelle Lavaud (15119297) (author), Paul van de Wiel (16617287) (author), Eveline den Biezen (16617290) (author), Yvonne Wesseling-Rozendaal (16617293) (author), Santiago Ponce (16617296) (author), Stefan Michiels (9081965) (author), Christophe Massard (14952598) (author), Daniel Gautheret (10927940) (author), Fabrice Barlesi (15045504) (author), Fabrice André (15038378) (author), Benjamin Besse (15061674) (author), Jean-Yves Scoazec (15036392) (author), Luc Friboulet (15025943) (author), Karim Fizazi (15093615) (author), Yohann Loriot (15123021) (author)
Gepubliceerd in:	2025
Onderwerpen:	Cancer Therapeutic Research and Development Drug Resistance Genitourinary Cancers Prostate cancer Translational Research
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items

Supplementary Data S1 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
door: Naoual Menssouri (16617248)
Gepubliceerd in: (2025)

Supplementary Data S10 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
door: Naoual Menssouri (16617248)
Gepubliceerd in: (2025)

Supplementary Data S11 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
door: Naoual Menssouri (16617248)
Gepubliceerd in: (2025)

Supplementary Data S12 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
door: Naoual Menssouri (16617248)
Gepubliceerd in: (2025)

Supplementary Data S13 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
door: Naoual Menssouri (16617248)
Gepubliceerd in: (2025)

Supplementary Data S14 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
door: Naoual Menssouri (16617248)
Gepubliceerd in: (2025)

Supplementary Data S2 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
door: Naoual Menssouri (16617248)
Gepubliceerd in: (2025)

Supplementary Data S3 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
door: Naoual Menssouri (16617248)
Gepubliceerd in: (2025)

Supplementary Data S4 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
door: Naoual Menssouri (16617248)
Gepubliceerd in: (2025)

Supplementary Data S5 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
door: Naoual Menssouri (16617248)
Gepubliceerd in: (2025)

Supplementary Data S7 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
door: Naoual Menssouri (16617248)
Gepubliceerd in: (2025)

Supplementary Data S8 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
door: Naoual Menssouri (16617248)
Gepubliceerd in: (2025)

Supplementary Data S9 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
door: Naoual Menssouri (16617248)
Gepubliceerd in: (2025)

Supplementary Figure S1 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
door: Naoual Menssouri (16617248)
Gepubliceerd in: (2025)

Supplementary Figure S2 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
door: Naoual Menssouri (16617248)
Gepubliceerd in: (2025)

Supplementary Figure S3 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
door: Naoual Menssouri (16617248)
Gepubliceerd in: (2025)

Supplementary Figure S4 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
door: Naoual Menssouri (16617248)
Gepubliceerd in: (2025)

Supplementary Figure S1 from Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer
door: Zachary Quinn (15052893)
Gepubliceerd in: (2025)

Supplementary Figure S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer
door: Aurelius Omlin (14971513)
Gepubliceerd in: (2025)

Supplementary Table S1 from Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer
door: Aurelius Omlin (14971513)
Gepubliceerd in: (2025)

Supplementary Figure S1 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
door: Ulka N. Vaishampayan (15051039)
Gepubliceerd in: (2025)

Supplementary Figure S2 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
door: Ulka N. Vaishampayan (15051039)
Gepubliceerd in: (2025)

Supplementary Figure S3 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
door: Ulka N. Vaishampayan (15051039)
Gepubliceerd in: (2025)

Supplementary Table S2 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
door: Ulka N. Vaishampayan (15051039)
Gepubliceerd in: (2025)

Supplementary Table S1 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
door: Sofie H. Tolmeijer (15313251)
Gepubliceerd in: (2025)

Supplementary Table S2 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
door: Sofie H. Tolmeijer (15313251)
Gepubliceerd in: (2025)

Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
door: Sofie H. Tolmeijer (15313251)
Gepubliceerd in: (2025)

Supplementary Table S1 from Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
door: Michael D. Nyquist (16918265)
Gepubliceerd in: (2025)

Supplemental Figures 1-4 from Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
door: Michael D. Nyquist (16918265)
Gepubliceerd in: (2025)

Supplementary File 2 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer
door: Charles Blatti (15292859)
Gepubliceerd in: (2025)

Supplementary File 3 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer
door: Charles Blatti (15292859)
Gepubliceerd in: (2025)

Supplementary File 4 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer
door: Charles Blatti (15292859)
Gepubliceerd in: (2025)

Supplementary Movie S1 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
door: Jesse C. Patterson (14962862)
Gepubliceerd in: (2025)

Supplementary Movie S2 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
door: Jesse C. Patterson (14962862)
Gepubliceerd in: (2025)

Supplementary Movie S3 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
door: Jesse C. Patterson (14962862)
Gepubliceerd in: (2025)

Supplementary Movie S4 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
door: Jesse C. Patterson (14962862)
Gepubliceerd in: (2025)

Supplementary Movie S5 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
door: Jesse C. Patterson (14962862)
Gepubliceerd in: (2025)

Supplementary Movie S6 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
door: Jesse C. Patterson (14962862)
Gepubliceerd in: (2025)

Supplementary Movie S7 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
door: Jesse C. Patterson (14962862)
Gepubliceerd in: (2025)

Supplementary Movie S8 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
door: Jesse C. Patterson (14962862)
Gepubliceerd in: (2025)

Cannot write session to /tmp/vufind_sessions/sess_blvokujftr4ptq27te88a3jv8k